CLINICAL_TRIALS
trial_result
· 2013-11-01
Clinical Trial Update: Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma [Phase 2]
Summary
Phase 2 trial evaluating cytarabine in young patients with recurrent or refractory Ewing's sarcoma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Oncology Group | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2013-11-01